Vycor Medical has presented results of a new study of its tubular retractor device, ViewSite Brain Access System (VBAS), which has been designed to assess the clinical performance to treat brain injuries.
VBAS is a suite of clear cylindrical minimally invasive disposable devices, which are designed to carry out safer and economical brain surgeries.
World Neurosurgery has published the results entitled "Use of Minimally Invasive Retractor System for Retrieval of Intracranial Fragments in Wartime Trauma."
Vycor Medical CEO Peter Zachariou said: "This high-quality clinical study evidences the clinical superiority of VBAS, which in turn drives its adoption and accelerates the hospital approval process."
Conducted at the Walter Reed National Military Medical Center, the study has been designed to explore whether the use of VBAS offered a valid and safe option to treat wartime penetrating brain injuries that resulted in deep-seated fragments, including shrapnel, bullets, and bone.
According to the firm, mechanism of injury was gunshot wound to the head and fragmentation injury to the head from improvised explosive devices.
VBAS has been used to facilitate removal of all the intraventricular or deep parenchymal fragments in the patients aged between 21 and 29 years.
It was used by surgeons in multiple different manners, depending on the depth, location and type of pathology being accessed and the fragment was successfully removed in all cases.
According to the firm, the study concluded that deep parenchymal and intraventricular fragments can be safely removed using VBAS.